FIELD: medicine.
SUBSTANCE: biological samples taken from the patients are analysed for apolipoprotein AI (Apo-AI) isoforms with oxidised residues of amino acids W50, W 108 and M 112.
EFFECT: use of the technique enables diagnosing hepatocellular carcinoma.
13 cl, 2 ex, 2 tbl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR DETECTING APOLIPOPROTEINS | 2016 |
|
RU2763404C2 |
| PEPTIDE POSSESSING ANTIATHEROSCLEROTIC ACTION AND COMPOSITION FOR PREVENTING AND TREATING ATHEROSCLEROTIC VASCULAR DISEASE | 2012 |
|
RU2495048C1 |
| LIPOPROTEIN COMPLEXES AND THEIR PREPARATION AND APPLICATION | 2012 |
|
RU2627173C2 |
| TRANSGENIC MICE EXPRESSING HUMAN LIPOPROTEIN (A) WITH DISCONNECTED VITAMIN C GENE, AND THEIR USE AS A DISEASE TREATMENT MODEL | 2014 |
|
RU2721254C2 |
| CONJUGATES AND COMPOSITIONS FOR IMMUNOTHERAPY AND ANTICANCER TREATMENT | 2010 |
|
RU2597989C2 |
| STABILISED COMPOUNDS OF EXENDIN-4 | 2003 |
|
RU2376314C2 |
| BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES-RELATED CONDITIONS | 2011 |
|
RU2596486C2 |
| ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCTION THEREOF | 2020 |
|
RU2824045C2 |
| RA ANTIGEN PEPTIDES | 2004 |
|
RU2359974C2 |
| CONJUGATES FOR ADMINISTERING BIOLOGICALLY ACTIVE COMPOUNDS | 2009 |
|
RU2567667C2 |
